Globally, the number of diabetes patients is at around half a billion with over 30 million in the US alone, the most sought after market for diabetes care companies, especially those into insulin.

Extending its gaining streak, shares of the pharma company surged as much as 17.58 per cent and touched 52-week high of Rs 694.20 apiece on BSE.

Cipla is recalling 4,800 bottles of Nevirapine extended-release tablets used for the treatment of HIV from the American market

\"Failing organs and tissues can be revived or replaced with the help of lab-grown and 3D-printed substitutes,\" says Dr K Ravindranath, Founder and Chairman, Gleneagles Global Hospitals Group.